FdaApplication
NDA 020459
Identifiers
- fda_app_no: NDA020459
Properties
| Property | Value |
|---|---|
| applicant_name | HIKMA PHARMS |
| application_type | NDA |
| approval_date | 1995-04-17 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| REVEX | NALMEFENE HYDROCHLORIDE | EQ 2MG BASE/2ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
| REVEX | NALMEFENE HYDROCHLORIDE | EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
2 products